1-2 of 2
Daniel A. Laheru
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival

Ludmila Danilova, Won Jin Ho, Qingfeng Zhu, Teena Vithayathil, Ana De Jesus-Acosta, Nilofer S. Azad, Daniel A. Laheru, Elana J. Fertig, Robert Anders, Elizabeth M. Jaffee, Mark Yarchoan
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (6): 886–895.
https://doi.org/10.1158/2326-6066.CIR-18-0822
Published: 03 June 2019
View article titled, Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival
Open the PDF for Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival in another window
Includes: Supplementary data
Journal Articles

Using Quantitative Seroproteomics to Identify Antibody Biomarkers in Pancreatic Cancer

Darshil T. Jhaveri, Min-Sik Kim, Elizabeth D. Thompson, Lanqing Huang, Rajni Sharma, Alison P. Klein, Lei Zheng, Dung T. Le, Daniel A. Laheru, Akhilesh Pandey, Elizabeth M. Jaffee, Robert A. Anders
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2016) 4 (3): 225–233.
https://doi.org/10.1158/2326-6066.CIR-15-0200-T
Published: 29 February 2016
View article titled, Using Quantitative Seroproteomics to Identify Antibody Biomarkers in Pancreatic Cancer
Open the PDF for Using Quantitative Seroproteomics to Identify Antibody Biomarkers in Pancreatic Cancer in another window
Includes: Supplementary data